Denver CO 非小细胞肺癌临床试验
27项针对 非小细胞肺癌的研究正在 Denver及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Franklin, Denver
- National Jewish Health-Main Campus, Denver
- Rocky Mountain Cancer Centers - Swedish, Englewood · 距离 6 英里
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at HealthOne, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Rocky Mountain Cancer Center, Denver
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Kaiser Permanente-Franklin, Denver
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- Rocky Mountain Cancer Centers,LLP, Denver
- Rocky Mountain Cancer Centers LLP, Denver
- Rocky Mountain Cancer Centers LLP, Englewood · 距离 6 英里
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
招募中1/2 期
- Rocky Mountain Cancer Centers,LLP, Denver
Pan-tumor MRD Study
招募中观察性研究
- The Melanoma and Skin Cancer Institute, Englewood · 距离 6 英里
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
招募中3 期
- National Jewish Health Medical Center, Denver
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- SCRI at HCA HealthONE, Denver
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
招募中3 期
- Clinical Study Site, Denver
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
招募中2/3 期
- Local Institution - 007-872-E, Denver
- Local Institution - 007-872-I, Denver
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at HealthOne, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
招募中1 期
- Sarah Cannon Research Institute Denver, Denver
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at HealthOne, Denver
SMP-3124LP in Adults With Advanced Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute at HealthOne, Denver
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
招募中1 期
- Sarah Cannon Research Institue At Healthone, Denver
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- Sarah Cannon Research Institute at HealthONE, Denver
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
招募中1 期
- Sarah Cannon Research Institute at HealthONE, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute, Denver
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- 以及另外 1 项
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Denver
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
招募中1/2 期
- Sarah Cannon Research Institute at HealthONE, Denver
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY121 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH57 项研究
- Washington, DC55 项研究
Denver的其他研究
- 转移性癌症29 项研究
- 乳腺癌29 项研究
- 多发性骨髓瘤27 项研究
- 结直肠癌23 项研究
- 黑色素瘤19 项研究
- 前列腺癌19 项研究
- 癌症（所有类型）18 项研究
- 卵巢癌16 项研究
- 肺癌16 项研究
- 子宫内膜癌15 项研究
- 非霍奇金淋巴瘤14 项研究
- 胰腺癌13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。